Vitamin D Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Vitamin D Therapy Market is segmented by Route of Administration (Oral and Parenteral), Purchasing Pattern, Application and Geography

Market Snapshot

vitamin d therapy market size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >11.8 %
vitamin d therapy market major companies

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors attributing to the growth of the market are the presence of a huge patient pool due to lack of time with sedentary lifestyles along with the rapid growth of the aging population. Also, an increased prevalence of malnutrition cases such as osteoporosis and rickets among all the age groups in recent years has escalated the awareness programs and healthcare expenditure by the government authorities across the globe. 

For instance, according to the (CDC) Centers for Disease Control and Prevention report, in 2018, about USD 3.65 trillions of national health care expenditure was incurred by the United States which is expected to increase throughout the forecast period providing better opportunities to the research activities and manufacturers driving the global vitamin D therapy market.

Scope of the Report

As per the scope of the report, Vitamin D is a group of fat-soluble secosteroids that are present only in few foods that are essential for the intestinal absorption of calcium, phosphate, and magnesium. When the skin is exposed to sunlight, it activates the synthesis of vitamin D from cholesterol. Among the vitamin D compounds, Vitamin D2 /ergocalciferol and vitamin D3 /cholecalciferol are considered to be essential for humans. The deficiency of these essential vitamins has been one of the most common problems in the past few years due to sedentary lifestyles leading to lesser exposure to sun resultant skin diseases, muscle weakness and bone pain driving the market.

By Route of Administration
By Purchasing Patterns
By Application
Muscle Weakness
Autoimmune Disorders
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Oral Route Of Administration is Expected to Hold the Major Market Share in the Vitamin D Therapy Market

The oral route of administration is expected to account for the largest share and highest CAGR over the forecast period. This dominance is owing to the ease of administration, safety, efficiency, reduced chances of toxicity coupled with patient compliance, and preference for the oral route due to availability in various forms like chewing gums and tablets, driving the global market.

Based on purchasing patterns, the prescription drugs segment accounts for the largest share as the preference for the diagnosis by the registered medical practitioners and prescribed therapies with appropriate medications. Also, the higher cost of Prescribed medicines compared to OTC drugs is expected for the highest market revenue propelling the global vitamin D market.

On the basis of application, the osteoporosis segment is expected to register the highest growth during the forecast period due to the growth of aging population, rise in the incidence of falls and fractures coupled with elevated levels of parathyroid hormones and the poor absorption of calcium from their diets which necessitates the Vitamin D therapy to enhance the calcium absorption.

vitamin d therapy market trends

North America Dominates the Vitamin D Therapy Market and is Expected to do Same in the Forecast Period

North America is expected to dominate the overall vitamin D therapy market throughout the forecast period. This dominance is mainly owing to the presence of leading players based in the United States, focus on research activities to develop more patient compliant products with enhanced efficiency coupled by the government support and increasing healthcare expenditure contributing to its outstanding market revenue share in the global vitamin D therapy market growth. 

The Asia Pacific market is also anticipated to witness the highest CAGR in the overall vitamin D therapy market during the forecast period. The significant growth in the region can be attributed to sedentary lifestyles, huge target patient pool due to heavy population in developing nations like India, China, and along with higher air pollution. Also, a rise in awareness programs about vitamin D deficiency by the government and manufacturers of emerging economies in the region is expected to boost the growth of the market propelling the global market revenue.

vitamin d therapy market growth

Competitive Landscape

The global Vitamin D therapy market is moderately competitive and consists of several major players. Some prominent players that are currently dominating the market In terms of market share are acquiring the products, entering into partnerships with the other companies to consolidate their market positions across the globe and while others are distributing products. Some of the companies which are currently dominating the market are Pfizer Inc, Abbott Laboratories, GlaxoSmithKline PLC, Biotics Research Corporation, and Ortho Molecular Products Inc.

Major Players

  1. Ortho Molecular Products Inc

  2. Biotics Research Corporation

  3. GlaxoSmithKline PLC

  4. Abbott Laboratories

  5. Pfizer Inc

Pfizer Inc, Abbott Laboratories, GlaxoSmithKline PLC, Biotics Research Corporation, Ortho Molecular Products Inc.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Huge Patient Pool with Sedentary Lifestyle and Rapidly Growing Aging Population

      2. 4.2.2 Rise in Awareness About Vitamin D Deficiency by the Government and Manufacturers

    3. 4.3 Market Restraints

      1. 4.3.1 Growing Consumption of Fortified Products

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Route of Administration

      1. 5.1.1 Oral

      2. 5.1.2 Parenteral

    2. 5.2 By Purchasing Patterns

      1. 5.2.1 Prescription

      2. 5.2.2 Over-The-Counter

    3. 5.3 By Application

      1. 5.3.1 Osteoporosis

      2. 5.3.2 Muscle Weakness

      3. 5.3.3 Autoimmune Disorders

      4. 5.3.4 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Ortho Molecular Products Inc.

      2. 6.1.2 Biotics Research Corporation

      3. 6.1.3 GlaxoSmithKline PLC

      4. 6.1.4 Abbott Laboratories

      5. 6.1.5 Pfizer Inc.

      6. 6.1.6 Novartis AG

      7. 6.1.7 Merck & Co Inc.

      8. 6.1.8 Cadila Healthcare Ltd.

      9. 6.1.9 Alkem Laboratories Ltd

      10. 6.1.10 Torrent Pharmaceuticals Ltd.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Vitamin D Therapy Market market is studied from 2018 - 2026.

The Vitamin D Therapy Market is growing at a CAGR of >11.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Ortho Molecular Products Inc, Biotics Research Corporation, GlaxoSmithKline PLC, Abbott Laboratories, Pfizer Inc are the major companies operating in Vitamin D Therapy Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!